Sentinel lymph nodes fluorescence detection and imaging using Patent Blue V bound to human serum albumin

Biomed Opt Express. 2012 Sep 1;3(9):2306-16. doi: 10.1364/BOE.3.002306. Epub 2012 Aug 30.

Abstract

Patent Blue V (PBV), a dye used clinically for sentinel lymph node detection, was mixed with human serum albumin (HSA). After binding to HSA, the fluorescence quantum yield increased from 5 × 10(-4) to 1.7 × 10(-2), which was enough to allow fluorescence detection and imaging of its distribution. A detection threshold, evaluated in scattering test objects, lower than 2.5 nmol × L(-1) was obtained, using a single-probe setup with a 5-mW incident light power. The detection sensitivity using a fluorescence imaging device was in the µmol × L(-1) range, with a noncooled CCD camera. Preclinical evaluation was performed on a rat model and permitted to observe inflamed nodes on all animals.

Keywords: (170.0170) Medical optics and biotechnology; (170.3880) Medical and biological imaging; (170.3890) Medical optics instrumentation; (170.6280) Spectroscopy, fluorescence and luminescence.